Gnosis Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.75 Cr
- Paid Up Capital ₹ 1.57 Cr
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 30.33 Cr
- Satisfied Charges ₹ 15.48 Cr
- Revenue Growth 23.07%
- Profit Growth 379.42%
- Ebitda 50.96%
- Net Worth 9.17%
- Total Assets 1.75%
About Gnosis Pharmaceuticals
Gnosis Pharmaceuticals Private Limited (GPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 March 2005 and has a history of 19 years and ten months. Its registered office is in Delhi, India.
The Corporate was formerly known as Kaizen Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.75 Cr and a paid-up capital of Rs 1.57 Cr.
The company currently has active open charges totaling ₹30.33 Cr. The company has closed loans amounting to ₹15.48 Cr, as per Ministry of Corporate Affairs (MCA) records.
Surendra Yadav, Mool Sonkar, Rajesh Khurana, and One other member serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24231DL2005PTC134162
-
Company No.
134162
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Mar 2005
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Gnosis Pharmaceuticals Private Limited offer?
Gnosis Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Allopathic Cough Syrup, Pharmaceutical Medicine, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Psoriasis Ointment, Anti Infective Drugs & Medicines, Anti Allergic Drug, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops.
Who are the key members and board of directors at Gnosis Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surendra Yadav
|
Additional Director | 04-Jul-2024 | Current |
|
Mool Sonkar
|
Director | 11-Jan-2021 | Current |
|
Rajesh Khurana
|
Director | 26-Nov-2011 | Current |
|
Ramesh Khurana
|
Director | 26-Nov-2011 | Current |
Financial Performance of Gnosis Pharmaceuticals.
Gnosis Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.07% increase. The company also saw a substantial improvement in profitability, with a 379.42% increase in profit. The company's net worth moved up by a moderate rise of 9.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gnosis Pharmaceuticals?
In 2023, Gnosis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Tycoon Pharmaceuticals Private LimitedRamesh Khurana is a mutual person
-
Wellchem Healthcare LlpRamesh Khurana is a mutual person
Charges (Loans)
₹30.33 Cr
₹15.48 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 28.95 Cr
- Tata Capital Housing Finance Limited : 1.08 Cr
- Director Of Industries : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Mar 2024 | Hdfc Bank Limited | ₹2.00 M | Open |
| 10 Dec 2021 | Hdfc Bank Limited | ₹2.50 M | Open |
| 10 Dec 2021 | Hdfc Bank Limited | ₹2.50 M | Open |
| 21 Nov 2020 | Hdfc Bank Limited | ₹28.25 Cr | Open |
| 13 Jul 2018 | Tata Capital Housing Finance Limited | ₹1.08 Cr | Open |
How Many Employees Work at Gnosis Pharmaceuticals?
Gnosis Pharmaceuticals has a workforce of 260 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gnosis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gnosis Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
